These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16821111)

  • 21. Coding and traceability: cells and tissues in North America.
    Brubaker SA; Wilson D
    Cell Tissue Bank; 2010 Nov; 11(4):379-89. PubMed ID: 20740378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. International Conference on Harmonisation; guidance on quality of biotechnological/biological products: derivation and characterization of cell substrates used for production of biotechnological/biological products; availability. Notice. Food and Drug Administration, HHS.
    Fed Regist; 1998 Sep; 63(182):50244-9. PubMed ID: 12269373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient safety or profit: what incentives are blood shield laws and FDA regulations creating for the tissue banking industry?
    Williams JL
    Indiana Health Law Rev; 2005; 2(1):295-328. PubMed ID: 17111505
    [No Abstract]   [Full Text] [Related]  

  • 24. The International Atomic Energy Agency (IAEA) program on radiation and tissue banking: a successful program for developing countries.
    Pedraza JM
    Cell Tissue Bank; 2006; 7(4):237-58. PubMed ID: 16821109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue transplantation. Quality assurance in the banking and utilization of musculoskeletal allografts.
    Kraft J; Alexander LA; Rowlands DT
    Physician Assist; 1992 Jun; 16(6):49-50, 53-6. PubMed ID: 10119847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Standards for humidification and filtration devices.
    Stevens J
    Respir Care Clin N Am; 2006 Jun; 12(2):203-32. PubMed ID: 16828691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Doctors hail new EU directive on tissues and cells.
    Burgermeister J
    BMJ; 2004 Jan; 328(7430):10. PubMed ID: 14703532
    [No Abstract]   [Full Text] [Related]  

  • 28. Quality indicators for the prevention and management of cardiovascular disease in primary care in nine European countries.
    Campbell SM; Ludt S; Van Lieshout J; Boffin N; Wensing M; Petek D; Grol R; Roland MO
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):509-15. PubMed ID: 18695594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Legal aspects of tissue banking.
    Gassner UM
    Pathobiology; 2007; 74(4):270-4. PubMed ID: 17709971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Standard Operating Procedures, ethical and legal regulations in BTB (Brain/Tissue/Bio) banking: what is still missing?
    Ravid R
    Cell Tissue Bank; 2008 Jun; 9(2):121-37. PubMed ID: 17985213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The health service in the European Community. What can await in the future EU-members?].
    Grewe R
    Klin Oczna; 2002; 104(3-4):299-301. PubMed ID: 12608324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Quality plan of a bone tissue bank].
    Lemercier V; Vastel L; Courpied JP
    Ann Pharm Fr; 2000 Dec; 58(6 Suppl):488-98. PubMed ID: 11148388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Raising the standard: changes to the Australian Code of Good Manufacturing Practice (cGMP) for human blood and blood components, human tissues and human cellular therapy products.
    Wright C; Velickovic Z; Brown R; Larsen S; Macpherson JL; Gibson J; Rasko JE
    Pathology; 2014 Apr; 46(3):177-83. PubMed ID: 24614714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TuBaFrost 3: regulatory and ethical issues on the exchange of residual tissue for research across Europe.
    van Veen EB; Riegman PH; Dinjens WN; Lam KH; Oomen MH; Spatz A; Mager R; Ratcliffe C; Knox K; Kerr D; van Damme B; van de Vijver M; van Boven H; Morente MM; Alonso S; Kerjaschki D; Pammer J; Lopez-Guerrero JA; Llombart Bosch A; Carbone A; Gloghini A; Teodorovic I; Isabelle M; Passioukov A; Lejeune S; Therasse P; Oosterhuis JW
    Eur J Cancer; 2006 Nov; 42(17):2914-23. PubMed ID: 17029786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality issues in skin banking: a review.
    Kearney JN
    Burns; 1998 Jun; 24(4):299-305. PubMed ID: 9688193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Navigating tissue banking regulation: conceptual frameworks for researchers, administrators, regulators and policy-makers.
    Lipworth W
    J Law Med; 2005 Nov; 13(2):245-55. PubMed ID: 16304764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Legal aspects of sea water quality: Turkish and EU directives.
    Dolgen D
    Water Sci Technol; 2005; 51(11):45-52. PubMed ID: 16114616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefit and risk of application of European tissue management regulation in ART.
    Scaravelli G
    Placenta; 2011 Sep; 32 Suppl 3():S243-7. PubMed ID: 21784519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulatory barriers to tissue-engineered products.
    Schutte E
    Med Device Technol; 2002 Mar; 13(2):27-9. PubMed ID: 11984990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The possibilities for the EU-wide use of similar ecological risk-based soil contamination assessment tools.
    Swartjes FA; Carlon C; de Wit NH
    Sci Total Environ; 2008 Dec; 406(3):523-9. PubMed ID: 18762322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.